https://www.indianpharmapost.com/lupin-receives-positive-chmp-opinion-for-biosimilar-ranibizumab-185922025-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-honored-as-2025-asia-ip-elite-by-iam-for-9th-consecutive-year-185932025-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-india-receives-permission-from-cdsco-for-datopotamab-deruxtecan-powder-185942025-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/godavari-biorefineries-launches-us-biotech-arm-to-advance-novel-cancer-therapies-185952025-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/mercks-keytrudapadcev-combo-delivers-survival-gains-in-phase-3-bladder-cancer-trial-185962025-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/astellas-pfizer-report-breakthrough-phase-3-results-in-muscle-invasive-bladder-cancer-185972025-12-18T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-nod-to-johnson-johnsons-akeega-for-aggressive-prostate-cancer-185982025-12-18T00:00:00+05:30always0.9